ceribell.comHealthcare / Medical DevicesFounded: 2014Funding to Date: $153.26MM
Ceribell is the developer of a highly innovative electroencephalography (EEG) device, designed to make the diagnosis of neurological patients drastically more efficient.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/22/2022 | Series C-NV | $2.8MM | $xx.xx | $326.5MM | Longitude Capital, The Rise Fund, RA Capital Management, Redmile Group, Red Tree Venture Capital, Ally Bridge Group | |
Price per Share
$xx.xx
Shares Outstanding
626,398
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Longitude Capital, The Rise Fund, RA Capital Management, Redmile Group, Red Tree Venture Capital, Ally Bridge Group
|
||||||
09/22/2022 | Series C-1 | $99.89MM | $xx.xx | $326.5MM | Longitude Capital, The Rise Fund, RA Capital Management, Redmile Group, Red Tree Venture Capital, Ally Bridge Group | |
Price per Share
$xx.xx
Shares Outstanding
22,347,373
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Longitude Capital, The Rise Fund, RA Capital Management, Redmile Group, Red Tree Venture Capital, Ally Bridge Group
|
||||||
09/25/2018 | Series B | $36.08MM | $xx.xx | $124.68MM | Optimas Capital Partners Fund, The Rise Fund, UCB, LivaNova | |
Price per Share
$xx.xx
Shares Outstanding
12,115,096
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Optimas Capital Partners Fund, The Rise Fund, UCB, LivaNova
|
||||||
05/03/2017 | Series A | $13.49MM | $xx.xx | $42.04MM | Shangbay Capital, DHVC | |
Price per Share
$xx.xx
Shares Outstanding
7,778,774
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Shangbay Capital, DHVC
|
||||||
08/31/2015 | Series Seed | $999,999 | $xx.xx | $5MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,130,799
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|